Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Treats T. vaginalis infection in females and males. Sold as Flagyl, Flagyl I.V. Rtu In Plastic Container, Metronidazole, Metro I.V., Protostat and 11 more. Every FDA application for this active ingredient: 29 branded and 63 generic.
As of Nov 15, 2026, FDA lists 92 applications for Metronidazole (sold as Flagyl, Flagyl I.V. Rtu In Plastic Container, Metronidazole and others), first approved Jul 18, 1963, with 5 new uses approved and 0 published complete response letters.
First approved: Jul 18, 1963
Applications: 92
New uses approved: 5
Complete response letters: 0
Medicare spending, 2025: $3.1M
Shortage: Current
Medicare Spending
CMS Part D and Part B, 2025, before manufacturer rebates; matched by generic name
Noritate
Part D
$3.0M
-9%
909
Likmez
Part D
$61K
New
116
Vandazole
Part D
$52K
-76%
529
Flagyl
Part D
$0K
-100%
0
Metrogel
Part D
$0K
-100%
0
Nuvessa
Part D
$0K
-100%
0
What Pharmacies Pay
Median price per unit across package codes in CMS's weekly NADAC survey, Nov 11, 2026, before rebates; see every drug's price change
METRONIDAZOLE 0.75% CREAM: $0.259 per GMGeneric · -16% in a year
METRONIDAZOLE 0.75% LOTION: $1.82 per MLGeneric · +0% in a year
METRONIDAZOLE 250 MG TABLET: $0.108 per unitGeneric · +32% in a year
METRONIDAZOLE 375 MG CAPSULE: $9.13 per unitGeneric · +17% in a year
METRONIDAZOLE 500 MG TABLET: $0.104 per unitGeneric · +0% in a year
LIKMEZ 500 MG/5 ML SUSPENSION: $2.60 per MLBrand · 0% in a year
AnaemetroA drug with a new additional pediatric dosage indicated for the treatment of anaerobic infection (sepsis, deep skin infection, secondary infections of… · Pfizer Japan Inc. · Nov 20, 2025
RozexA drug with a new indication and a new dosage for the treatment of rosacea. · Maruho Co., Ltd. · May 26, 2022
Rozex, new approvalA drug with a new route of administration indicated for disinfection/deodorisation of odorous fungating tumours. · Galderma S.A. · Dec 26, 2014
Anaemetro, new approvalA drug with a new route of administration indicated for the treatment of different kinds of anaerobic bacterial infections, infectious enteritis, and amebic… · Pfizer Japan Inc. · Jul 4, 2014
FlagylA drug with new additional indications and a new dosage for the treatment of anaerobic bacterial infection, infectious enteritis, amoebic dysentery, and… · Shionogi & Co., Ltd. · Aug 10, 2012
FlagylDrugs with a new indication and new dosages for the treatment of bacterial vaginosis. · Shionogi & Co., Ltd. · Mar 21, 2012
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient.Drugs@FDA